Wegovy consent form

A Wegovy consent form is crucial in aesthetic treatments as it ensures patient safety while providing clear communication about the procedure, potential risks, and benefits. This transparency fosters trust and empowers patients to make informed decisions regarding their treatment options. By outlining important information, it serves as a vital document in the commercial and transactional aspects of aesthetic practice, reinforcing the ethical responsibility of practitioners.

What is Wegovy?

Wegovy is a prescription weight management medication containing semaglutide, designed to help individuals achieve sustainable weight loss. It works by mimicking a hormone that regulates appetite and caloric intake. While primarily for body weight, it can indirectly enhance facial areas by promoting an overall slimmer appearance.

What kind of treatment is the Wegovy consent form for?

Wegovy is a non-surgical injectable treatment designed to aid in weight management for adults with obesity or overweight conditions.

Administered weekly, it contains semaglutide, mimicking a hormone that regulates appetite.

Intended for individuals with a BMI of 30 or above, or 27 with related health conditions.

Typical outcomes include significant weight loss, improved metabolic health, and enhanced quality of life.

As with any medication, rare side effects may occur; consult your healthcare provider for detailed information.

Why you must sign a consent form

It is a legal and ethical requirement in the UK
Confirms you understand the treatment and possible side effects
Helps set realistic expectations and ensures safe practice
Builds trust between you and your practitioner
Your signed confirmation of informed consent

Potential side effects of Wegovy treatments

Wegovy treatments may result in various side effects that users should be aware of.

Nausea

Diarrhoea

Vomiting

Constipation

Abdominal pain

Rare side effects may include pancreatitis and kidney issues.

Who is the ideal candidate for this treatment?

The ideal candidate for Wegovy treatment is typically an adult struggling with obesity or weight-related health issues.

Adults with a BMI of 30 or more

Those with a BMI of 27 with weight-related conditions

Not pregnant or planning pregnancy

No history of allergic reactions to the medication

Free from certain medical conditions, such as a personal or family history of medullary thyroid carcinoma

Consult a healthcare professional for personalised advice.

Aftercare advice for best results

Proper aftercare for Wegovy is essential for achieving the best results.

Stay hydrated and maintain a balanced diet.

Engage in regular physical activity as advised.

Monitor your weight and report any concerns to your doctor.

Attend follow-up appointments as scheduled.

Always consult your healthcare provider for personalised advice.

How to fill the consent form?

To complete the consent form, carefully read each section outlining the treatment, potential risks, and expected outcomes. Ensure you understand all information before proceeding. Fill in personal details accurately and confirm agreement by ticking the required boxes. The form must be signed digitally to confirm your informed consent.